Immunogenicity of a combined diphtheria–tetanus–acellular pertussis vaccine in adults
P Van Damme, M Burgess - Vaccine, 2004 - Elsevier
Two clinical studies were undertaken to evaluate the immunogenicity of an adult-type dTpa
booster vaccine (Boostrix™ by GlaxoSmithKline Biologicals). Blood samples taken prior to …
booster vaccine (Boostrix™ by GlaxoSmithKline Biologicals). Blood samples taken prior to …
A randomised controlled trial with a diphtheria–tetanus–acellular pertussis (dTpa) vaccine in adults
M Van der Wielen, P Van Damme, E Joossens… - Vaccine, 2000 - Elsevier
The aim of this assessor-blinded trial was to compare the immunogenicity and reactogenicity
of a candidate diphtheria, tetanus toxoids and acellular pertussis vaccine with reduced …
of a candidate diphtheria, tetanus toxoids and acellular pertussis vaccine with reduced …
A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults
FM Turnbull, TC Heath, BB Jalaludin, MA Burgess… - Vaccine, 2000 - Elsevier
A single blinded randomized controlled trial to compare the reactogenicity and
immunogenicity of adult formulated dTpa and monovalent pa vaccines with a licensed Td …
immunogenicity of adult formulated dTpa and monovalent pa vaccines with a licensed Td …
Immunogenicity and reactogenicity of a single dose of a diphtheria–tetanus–acellular pertussis component vaccine (DTaP) compared to a diphtheria–tetanus toxoid …
I Bartels, J Jüngert, S Lugauer, K Stehr, U Heininger - Vaccine, 2001 - Elsevier
We compared immunogenicity and reactogenicity of a single dose of DTaP vaccine
(containing tetanus and diphtheria toxoids and four acellular pertussis antigens) with …
(containing tetanus and diphtheria toxoids and four acellular pertussis antigens) with …
High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine
PB McIntyre, FM Turnbull, AM Egan, MA Burgess… - Vaccine, 2004 - Elsevier
There is increasing interest in prevention of pertussis in adults by vaccination, but little is
known about the duration of the antibody response to pertussis, diphtheria or tetanus in …
known about the duration of the antibody response to pertussis, diphtheria or tetanus in …
Development and clinical testing of multivalent vaccines based on a diphtheria–tetanus–acellular pertussis vaccine: difficulties encountered and lessons learned
C Capiau, J Poolman, B Hoet, H Bogaerts, F Andre - Vaccine, 2003 - Elsevier
The widespread use of whole-cell pertussis vaccines in the second half of the 20th century
have reduced the incidence of the disease significantly. However, in some countries …
have reduced the incidence of the disease significantly. However, in some countries …
[PDF][PDF] Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults
SH Chan, PTN Tan, HH Han, HL Bock - Singapore medical journal, 2006 - smj.org.sg
Introduction: Older children and adults, susceptible to pertussis because of waning
immunity, may serve as a reservoir of infection, leading to severe disease among young …
immunity, may serve as a reservoir of infection, leading to severe disease among young …
Reduced-antigen combined diphtheria-tetanus-acellular pertussis vaccine (Boostrix™)
TM Chapman, KL Goa - Drugs, 2003 - Springer
Abstract▴ The reduced-antigen combined diphtheria-tetanus-acellular pertussis vaccine
(dTpa) is intended for use as a booster dose in individuals aged≥ 4 years.▴ A single dose …
(dTpa) is intended for use as a booster dose in individuals aged≥ 4 years.▴ A single dose …
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) …
B Thierry-Carstensen, K Jordan, HH Uhlving, T Dalby… - Vaccine, 2012 - Elsevier
BACKGROUND: Increasing incidence of pertussis in adolescents and adults has stimulated
the development of safe and immunogenic acellular pertussis vaccines for booster …
the development of safe and immunogenic acellular pertussis vaccines for booster …
Reactogenicity and immunogenicity of reduced antigen content diphtheria–tetanus–acellular pertussis vaccine (dTpa) administered as a booster to 4–6 year-old …
P Kosuwon, B Warachit, Y Hutagalung, T Borkird… - Vaccine, 2003 - Elsevier
A trial to compare the reactogenicity and immunogenicity of a reduced antigen content
diphtheria–tetanus–acellular pertussis (dTpa) vaccine with diphtheria–tetanus–whole-cell …
diphtheria–tetanus–acellular pertussis (dTpa) vaccine with diphtheria–tetanus–whole-cell …
相关搜索
- diphtheria tetanus pertussis vaccine
- diphtheria tetanus antigen content
- antigen content pertussis vaccine
- diphtheria tetanus singaporean adults
- diphtheria tetanus immunogenicity and reactogenicity
- singaporean adults pertussis vaccine
- immunogenicity and reactogenicity pertussis vaccine
- diphtheria tetanus dtpa ipv
- clinical testing pertussis vaccine
- diphtheria tetanus high levels
- high levels pertussis vaccine
- singaporean adults immunogenicity and reactogenicity
- diphtheria tetanus repeated administration
- combined diphtheria pertussis vaccine